Coronary Artery Calcification, In Stent Restenosis, Intravascular Lithotripsy
Conditions
Brief summary
The IVL-Dragon Registry was a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL in high-volume PCI centers. The primary efficacy endpoint was clinical success, defined as a reduction of stent underexpansion to \<30% with no evidence of in-hospital device-oriented composite end point (DOCE) (defined as a composite of cardiac death, target lesion revascularization, and target vessel myocardial infarction).
Interventions
DEVICEPercutaneous Coronary Intervention
Intravascular lithotripsy (IVL)
Sponsors
Wojciech Wojakowski
Medical University of Silesia
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* stent underexpansion treated with intravascular lithotripsy (IVL)
Exclusion criteria
* no
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical Success | 30 days | Reduction of stent underexpansion to the value of \<30% with no evidence of in-hospital device-oriented composite end point (DOCE) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| DOCE | 30 days | composite of cardiac death, target lesion revascularization (TLR), target lesion revascularization, (TLR), and target vessel myocardial infarction (MI) |
Countries
Poland
Outcome results
None listed